David Arkowitz Flexion Therapeutics Inc (FLXN) insider trading activity
David Arkowitz is Chief Financial Officer of Flexion Therapeutics Inc. Currently has a direct ownership of 220,719 shares of FLXN, which is worth approximately $2.02 Million. The most recent transaction as insider was on May 10, 2021, when has been sold 2,229 shares (Common Stock) at a price of $7.23 per share, resulting in proceeds of $16,116. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
221K
0%
3M change
0%
12M change
Total Value Held
$2.02 Million
David Arkowitz Transaction History
Also insider at
DA
David Arkowitz
Chief Financial Officer
Cambridge, MA